Key Record Dates
| ClinicalTrials.gov Identifier: | NCT02676349 |
|---|---|
| Brief Title: | Neoadjuvant mFolfirinox With or Without Preoperative Concomitant Chemoradiotherapy in Patients With Borderline Resectable Pancreatic Carcinoma (PANDAS-PRODIGE 44) |
| First Submitted : | February 3, 2016 |
| First Submitted that Met QC Criteria : | February 3, 2016 |
| First Posted : | February 8, 2016 (Estimate) |
| Last Update Submitted that Met QC Criteria : | August 11, 2020 |
| Last Update Posted : | August 12, 2020 |